A new study being conducted in France and Switzerland aims to expand scientific knowledge of the connection between birth defects and antidepressants in a class known as selective serotonin reuptake inhibitors (SSRIs). Some of the most-prescribed drugs in the U.S. are SSRIs, including Zoloft.
The study will involve roughly 500 mothers, including those who plan to take antidepressants like Zoloft during pregnancy and while breast feeding, and those who do not. The primary study data will be available in August 2015, with the full study available in 2018.
Zoloft has already been linked to severe birth defects among children born to women who use the drug during pregnancy. Zoloft birth defects include heart defects, omphalocele, brain defects and persistent pulmonary hypertension of the newborn (PPHN).